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Abstract
Msx and Dlx homeoproteins control the morphogenesis and organization of craniofacial skeletal structures, specifically those derived from the
pharyngeal arches. In vitro Msx and Dlx proteins have opposing transcriptional properties and form heterodimeric complexes via their
homeodomain with reciprocal functional repression. In this report we examine the skeletal phenotype of Msx1; Dlx5 double knock-out (DKO)
mice in relationship with their expression territories during craniofacial development. Co-expression of Dlx5 and Msx1 is only observed in
embryonic tissues in which these genes have independent functions, and thus direct protein interactions are unlikely to control morphogenesis of
the cranium. The DKO craniofacial phenotypes indicate a complex interplay between these genes, acting independently (mandible and middle
ear), synergistically (deposition of bone tissue) or converging on the same morphogenetic process (palate growth and closure). In the latter case,
the absence of Dlx5 rescues in part the Msx1-dependent defects in palate growth and elevation. At the basis of this effect, our data implicate the
Bmp (Bmp7, Bmp4)/Bmp antagonist (Follistatin) signal: in the Dlx5K/K palate changes in the expression level of Bmp7 and Follistatin counteract
the reduced Bmp4 expression. These results highlight the importance of precise spatial and temporal regulation of the Bmp/Bmp antagonist system
during palate closure.
q 2005 Elsevier Ireland Ltd. All rights reserved.
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The mammalian face develops from the coordinated growth,
morphogenesis and fusion of several embryonic primordia: the
frontonasal processes, two maxillary and two mandibular
prominences, located around the primitive mouth. The
maxillary and mandibular prominences derive from the first0925-4773/$ - see front matter q 2005 Elsevier Ireland Ltd. All rights reserved.
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land, St Lucia, Australia.pharyngeal arch whose mesenchyme is colonized predomi-
nantly by neural crest-derived skeletogenic cells. Ventrally to
the mouth, the mandibular arches fuse in the midline and give
rise to the skeletal elements of the mandible. Dorsally to the
mouth, the maxillary prominences grow and fuse anteriorly
with the frontonasal processes, giving rise to the upper lip and
the primary palate. The secondary palate develops bilaterally
as two shelves that grow from the internal surface of the
maxillae and first project vertically along the sides of the
tongue (E12–E13). The shelves then elevate and become
oriented horizontally, eventually they fuse with each other,
with the base of the nasal septum and with the primary palate
(E14–E15) (Ferguson, 1998).
The comprehension of the genetic regulation at the basis of
craniofacial patterning and morphogenesis is a formidable taskMechanisms of Development 123 (2006) 3–16www.elsevier.com/locate/modo
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phenotypes in mutant mouse strains (Wilkie and Morris-Kay,
2001; Francis-West et al., 2003; Couburne and Sharpe, 2003;
Richman and Lee, 2003; Thyagarajan et al., 2003; Murray and
Schutte, 2004). Among the many gene families that have been
implicated, the closely related Dlx and Msx homeobox
transcription factors gene play a central role (Davidson,
1995; Depew et al., 1999; 2002; Merlo et al., 2000; 2003;
Bendall and Abate-Shen, 2000; Beverdam et al., 2002;
Panganiban and Rubenstein, 2002). Msx1 and Msx2 are widely
expressed at many embryonic sites, in particular those where
epithelial-mesenchyme interactions take place (Davidson,
1995; Bendall and Abate-Shen, 2000). During early head
development, Msx1 and Msx2 are expressed in migrating
neural crest cells, which populate the distal regions of the
arches and the frontonasal processes (Bendall and Abate-Shen,
2000; Alappat et al., 2003 and references therein). Similarly,
Dlx genes are expressed in a proximal-distal combinatorial
pattern in the pharyngeal arches (Depew et al., 2002; Merlo
et al., 2003). Differential expression of Dlx genes in the arches
suggest that they confer positional identity on the skeletogenic
cells, this notion being supported by the analysis of craniofacial
phenotypes in single and double knock-out (DKO) mice
(Beverdam et al., 2002; Depew et al., 2002). At later
embryonic stages, the partially overlapping expression of the
various members of the Dlx and Msx gene families is thought to
mediate epithelial-mesenchymal interactions leading to correct
induction, growth and morphogenesis of embryonic structures
such as the teeth, the palate, the mandible (Bendall and
Abate-Shen, 2000 and references therein).
In the Msx1K/K mice severe craniofacial defects are
observed, including palatal cleft, due to failure of the shelves
to elevate and fuse, mandible and middle ear ossicle deformity,
absence of molars and delayed ossification (Satokata and Maas,
1994). All these defects have been associated to the expression
of Msx1 in the corresponding embryonic territories. In the Dlx5
null mice, similar skeletal structures are affected, including the
palate, the mandible, the middle ear ossicles; these mice exhibit
also a generalized delay in the ossification process in the
calvaria (Acampora et al., 1999; Depew et al., 1999; Merlo
et al., 2000; 2003). The similarity of the skeletal elements
affected by Msx1 or Dlx5 mutation prompted us to investigate a
possible interplay between these genes.
In vitro, the Msx and Dlx proteins appear to have opposing
transcription properties with Msx functioning as repressors and
Dlx as activators (Alappat et al., 2003; Panganiban and
Rubenstein, 2002). In vitro, Msx1, Dlx2 and Dlx5 recombinant
proteins form heterodimers via their homeodomain and, by
doing so, they reciprocally inhibit their activities (Zhang et al.,
1997). Should this observation hold true in vivo, some of the
phenotypes observed in Msx1K/K mice may be due to altered
Dlx5 activity, and viceversa. In this case, one might expect that
in Msx1; Dlx5 DKO mice some of the defects be aggravated or
rescued. The essential condition for this regulation to occur is
that the two genes be expressed in the same cells at the same
time, as proposed by Zhang and coworkers (1997). In this
study, we first examined the expression pattern of Msx1and Dlx5 in the craniofacial primordium. Next, we generated
Msx1; Dlx5 DKO mice and examined their phenotype
compared to those of single mutants. In most structures, the
two genes are expressed in separate territories and seem to act
independently. On the contrary, the absence of Dlx5 partially
rescues the palatal defects of Msx1 null mice, although there is
no co-expression. We analyzed the signals possibly involved in
this regulation and provide data that implicate the Bmp/Bmp-
antagonist signal in the process genetically controlled by Dlx5
and Msx1 in palate formation.
2. Results
2.1. Frequency of Msx1–Dlx5 DKO mice
Msx1nlacZ mice were crossbred with Dlx5lacZ mice, double
heterozygous males and females were obtained at the expected
frequency. Crossbreeding of double heterozygotes yielded
Msx1K/K; Dlx5K/K embryos and pups at a frequency lower
than expected (5/98, 5.1 vs. 6.25%, not statistically significant).
All delivered DKO, as well as single Msx1K/K and Dlx5K/K
animals, died soon after delivery.
2.2. Expression of Dlx5 and Msx1 in craniofacial structures
At the E10.5 stage of development, Msx1 and Dlx5 are co-
expressed in the distal mandibular arch (Bendall and
Abate-Shen, 2000, Fig. 3). We have compared expression of
Msx1 and Dlx5 at later stages by X-gal staining of serial
sections of Msx1nlacZ and Dlx5lacZ heterozygous (normal)
embryos at E13.5 and E14.5 (Figs. 1, 6). In situ hybridization
on relevant sections was used to confirm the endogenous
expression.
In the anterior palate region, marked by the vomeronasal
organs (VNO), Msx1, but not Dlx5, is expressed in the
mesenchyme, in the chondrogenic tissue surrounding the VNO
and in a wide region of the maxilla mesenchyme (Fig. 1B,D).
Dlx5, but not Msx1, is expressed in the VNO and the olfactory
epithelium (Fig. 1A,C) (Levi et al., 2003). Co-expression of
Msx1 and Dlx5 is limited to the most lateral region of the
maxillary mesenchyme (Fig. 1A,B). In the posterior palate
region, marked by the molar tooth buds, neither Msx1 not Dlx5
are expressed. Instead, co-expression of Msx1 and Dlx5 is
found in the maxilla mesenchyme corresponding to osteogenic
areas (Fig. 1C,D). Msx1 is also strongly expressed in the molar
tooth papillae, while Dlx5 is expressed in the osteogenic
mesenchyme surrounding the tooth (Figs. 1, 6) and in the
enamel knot cells. Neither Msx1 nor Dlx5 are expressed in the
dental epithelium (Bendall and Abate-Shen, 2000; Alappat
et al., 2003; Merlo et al., 2003). In summary Msx1 is expressed
in the anterior, but not in the posterior, palate (see also Zhang
et al., 2002; Nugent and Green, 1998; Givens et al., 2005)
while Dlx5 is not expressed in either the anterior or the
posterior palate. We then examined the distribution of lacZ
expressing cells in the palate, comparing Msx1 and Dlx5
heterozygous embryos with the corresponding homozygous
ones (Fig. 1E–H). lacZ expression is maintained in the correct
Fig. 1. Expression of Dlx5 and Msx1 in craniofacial structures. (Top) expression of Dlx5lacZ and Msx1nlacZ by X-gal staining of frontal sections of normal
(heterozygous) E14.5 embryos. The anterior (A,B) and posterior palatal regions (C,D), marked respectively by the VNO and the molar tooth buds, are shown.
(Bottom) same as above, applied to compare a normal (on the left) with a mutant (on the right) E14.5 embryo. Palatal shelves are indicated with black arrows, molar
buds are indicated with red arrowheads. Genotypes for Dlx5 and Mxs1 are reported. Abbreviations: Mo, molar buds; OE, olfactory epithelium, PS, palatal shelves; T,
tongue, VNO, vomeronasal organ.
G. Levi et al. / Mechanisms of Development 123 (2006) 3–16 5position in both the Msx1K/K and Dlx5K/K. Thus, it is unlikely
that the palatal phenotypes observed in these mutant mice and
the rescue observed in the DKO head be caused by a missing
cell population.2.3. The palatal phenotype
In the Msx1 null mice the palatal shelves fail to elevate from
a vertical to an horizontal position; consequently they do not
fuse and remain opened, with the base of the nasal septum is
exposed in the oral cavity (Figs. 1H, 2A,G,H) (Satokata and
Maas, 1994; Houlzestein et al., 1997). In the Dlx5 null mice,the palatal shelves are partially formed and elevated but fail to
complete growth and to fuse in the midline (Fig. 2E,F)
(Acampora et al., 1999; Depew et al., 1999). While the Msx1
phenotype is fully penetrant, the Dlx5 one shown in Fig. 2 is the
most common of a range of phenotypes; in the more severe
(rare) form a near complete opening of the palatal shelves is
observed, while in the mildest form (also rare) the shelves grow
and elevate to come into contact, however, they fail to fuse. In
DKO E13.5 embryos (2/2) the shelves are partly formed and
elevated (Fig. 2B), but do not come to contact and fuse. At P0
the shelves are present, elevated, and partially ossified (3/3),
although fail to fuse in the midline. This leads to the condition
Fig. 2. Rescue of the Msx1 palatal defects in Msx1-Dlx5 DKO mice. (A,B)
Histology of the palate of Msx1K/K and DKO E13.5 embryos. (C–K) Skeletal
preparation of WT (C,D), Dlx5K/K (E,F), Msx1K/K (G,H) and DKO (J,K)
mice, at P0. The picture on the right is a higher magnification of the one on the
left, detailing the palatal region. The presphenoid bone (Pr) and the palatal
shelves (black arrows) are indicated, the absence of the palatal shelves in the
Msx1K/K head (H) is indicated with asterisks. A drawing of the palatal shelves
is shown on the right, for clarity.
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null mice. This observation indicates that the severe Msx1-
related palatal phenotype can be partially rescued in the DKO
head.
We set forth to investigate the molecular regulation at the
basis Dlx5-dependent rescue of the Msx1 palate phenotype. In
Msx1K/K embryos a reduced expression of Shh, Bmp4 and
Bmp2 in the medial edge epithelium (MEE) and mesenchyme
of the anterior region has been reported (Zhang et al., 2002).
The restoration of Bmp4 expression in the palate of Msx1K/K
mice could partially rescue the growth and elevation of the
shelves (Zhang et al., 2002). It seemed therefore likely that the
loss of Dlx5 might infringe on the Bmp expression and/or
regulation. Since Dlx5 is not expressed in the Bmp2-4 territory,such putative function of Dlx5 should be non-cell-autonomous,
and might reasonably include the secreted Bmp antagonist
Noggin, Chordin, Follistatin. Alternatively, Msx1 might
repress Dlx5 transcription, and Dlx5, in turn, might normally
inhibit cell proliferation of the palatal mesenchyme. We tested
both of these hypotheses.
2.4. Expression of Dlx5 and Dlx6 is not altered
in Msx1K/K mice
Expression of Dlx5 and Msx1 in the developing head
appears to be complementary (Fig. 1). For this reason, the
possibility that the Msx1 protein may normally repress Dlx5
expression in the palate appeared likely. We have examined
expression of Dlx5 in E11 Msx1K/K embryos by whole-mount
in situ hybridization. As shown in Fig. 3A–D, expression of
Dlx5 was detected both in the WT and in the Msx1K/K
embryos in the expected territories (1st and 2nd pharyngeal
arches, ventral cephalic epithelium, olfactory and otic
epithelium) with no appreciable difference. These results
indicate that Dlx5 is not under transcription control of Msx1.
We also examined expression of Msx1 (Fig. 3E, F) and Msx2
(not shown) in the pharyngeal arches of E10.5Dlx5K/K
embryos. In both WT and mutant embryos Msx1 is expressed
in the expected territories (distal mandibular arch, maxillary
arch, mesenchyme of the frontonasal processes, limbs) with no
significant difference.
Msx1 could inhibit Dlx5 expression at a later stage of palate
formation. We have therefore examined Dlx5 expression in
sections of E14.5 normal and Msx1K/K heads by in situ
hybridization. As shown in Fig. 3G, H, expression of Dlx5 in
the anterior palate is undetectable in both the WT and the
Msx1K/K palate. Instead, in the posterior palate, Dlx5
expression is slightly expanded toward the midline in the
Msx1K/K palate (Fig. 3J, K). This region, however, does not
overlap with either the Msx1 or Bmp4 expression territories
(Zhang et al., 2002). Finally, Dlx5 expression is observed in the
lateral maxillary mesenchyme equally in the normal and in the
Msx1K/K head, and is unchanged in all other embryonic
territories. These results suggest that Dlx5 expression in vivo is
largely independent of Msx1.
2.5. Expression of Bmps and Bmp antagonists in Msx1
and Dlx5 mutant embryos
Dlx5 could directly act as an inhibitor of Bmp4 expression,
or could modulate Bmp function by regulating the expression
of Bmp antagonists, such as Noggin, Chordin, or Follistatin.
Bmp4 is expressed at sites of fusion between prominences of
the head primordium, including the palate (Gong and Guo,
2003). In E13–E14 embryos Bmp4 is expressed in a restricted
domain of the anterior palate mesenchyme, adjacent to the
MEE (Fig. 4A,D). Importantly, several genes coding for
morphogenetic molecules, including Bmp2, Bmp4, Bmp7,
Follistatin, Shh and FGFs, are expressed in this location.
This domain can be considered a signaling center for palate
growth. In the Msx1K/K palate at E13.5 and E14.5 Bmp4
Fig. 3. Expression of Dlx5 in Msx1K/K embryos. (Top) whole-mount
hybridization with Dlx5 probe on Msx1K/K E10.5 embryos (A–D), and with
Msx1 probe on Dlx5K/K E11embryos (E,F). A,B,E,F, lateral view; C,D, frontal
view. Msx1 and Dlx5 signal on the 1st arch is indicated (black arrows). Msx1
hybridization is also observed on the maxillary arch and the frontonasal
3
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not absent (Zhang et al., 2002; Fig. 4C). Likewise, Bmp4
expression is reduced in the Dlx5K/K palate (Fig. 4B,E) and is
nearly absent in the DKO (Fig. 4E’). To control for tissue
preservation and hybridization specificity, the Bmp4 signal on
the incisor tooth dental papillae in the same sections were
compared and found to be equal (insets in Fig. 4D,E).
We then examined the expression of Bmp7 in the palate of
Dlx5K/K, Msx1K/K and DKO embryos at E13.5 and E14.5. At
E13.5 Bmp7 is normally expressed in the signaling center of the
anterior palate in both the epithelium and the underlying
mesenchyme (Fig. 4J,L). Bmp7 expression extends along the
anterior-posterior length of the shelves (Fig. 4F–H), where it is
found in the palatal epithelium, but not in the mesenchyme
(Fig. 4N,P). Whole-mount in situ hybridization on WT,
Dlx5K/K and Msx1K/Kheads showed a similar level of Bmp7
expression (Fig. 4F–H); however hybridization on Dlx5K/K
palates shows an increase in Bmp7 signal both anteriorly
(Fig. 4K) and posteriorly (data not shown). In the Msx1K/K
palate Bmp7 expression is decreased anteriorly, but increased
posteriorly. Finally, Bmp7 expression was found to be
increased in the DKO palate (Fig. 4K’). To control for tissue
preservation and specificity of the hybridization, the Bmp7
signal on the eye lids in the same sections were compared
(insets in Fig. 4J,K,M) and the results are summarized in Fig. 7.
To confirm the previous finding, Bmp7 mRNA level in WT,
Msx1K/K and Dlx5K/K palatal shelves was quantified by
RealTime PCR (Fig. 4N). A 1.5 and a 1.6 fold increase in the
Bmp7 template was observed, respectively, in the Msx1K/K
and in the Dlx5K/K RNA sample, in two experiments (with
biological replicates). The increased Bmp7 expression cannot
be attributed to a direct Dlx5 regulation, and therefore a non-
cell-autonomous effect is the most likely mechanism.
Expression of the Bmp-antagonist molecules, Noggin,
Chordin, and Follistatin was examined in E13.5 and E14.5
Dlx5 mutant heads. At E13.5 Follistatin expression is normally
restricted to a dorsal (nasal) domain of the anterior palate
epithelium; in Dlx5K/K palates this expression domain is
unchanged (Fig. 5A,B). In the Msx1K/K palate, expression in
this region was reduced and irregularly distributed (Fig. 5C).
Posteriorly, Follistatin is expressed in the palatal epithelium,
with higher expression on the tip and on the ventral (oral)
domain (Fig. 5E). In the Dlx5K/K palate Follistatin expression
in the mid-posterior region was reduced and irregularly
distributed (Fig. 5F). In the posterior palate of Msx1K/K
embryos Follistatin expression is detected at levels similar to
the WT (Fig. 5G). In DKO embryos, Follistatin expression is
reduced both anteriorly and posteriorly (Fig. 5D,H). To control
for tissue preservation and hybridization specificity, Follistatinprocess. Dlx5 signal is also observed on the 2nd arch, the olfactory placodes,
the otic vesicle. (Bottom) Hybridization with Dlx5 probe on frontal sections of
the anterior (G,H) and posterior (J,K) palate of E14.5 Msx1K/K embryos.
Expression is observed in a lateral domain, corresponding to the maxilla. In the
Msx1K/K head the Dlx5 territory is slightly expanded towards the midline
(sketched with a dotted red line). Abbreviations: FNP, frontonasal process; Mx,
maxillary arch; OP, olfactory placodes; OV, otic vescicle; Se, septum (nasal);
2nd, second (hyoid) arch; other abbreviations as in previous figures.
Fig. 4. Expression of Bmp4 and Bmp7 in Dlx5K/K, Msx1K/K and DKO embryos. (A–C) Whole-mount in situ hybridization for Bmp4 on the palate of WT (A),
Dlx5K/K (B), Msx1K/K (C) E13.5 embryos, in ventral view. Bmp4 signal in the palatal shelves is indicated with red arrowheads, or red asterisks in case of reduced
expression. (D–E’) Hybridization for Bmp4 on frontal sections of WT (D), Dlx5K/K (E) and DKO (E’) embryonic heads at E13.5. (F–H) Whole-mount in situ
hybridization for Bmp7 on the palate of WT (F), Dlx5K/K (G) and Msx1K/K (H) embryos at E13.5, in ventral view. The signal in the palatal shelves is indicated with
red arrowheads. (J–P) Hybridization with Bmp7 probe on frontal sections of the palate of WT (J,L,N), Dlx5K/K (K), Msx1K/K (M,P) and DKO (K’) embryos.
Sections of the anterior (J,K’,L,M) and posterior (N,P) palate are shown. Relevant Bmp7 signal in the palate epithelium and mesenchyme is indicated with red
arrows, signal on the molar tooth is indicated with black arrows (N,P). The drawing on the right clarifies the section and the viewing planes adopted. Controls for
specific and equal hybridization signal from the same experiments (eye lids for Bmp7, incisor teeth for Bmp4) are shown in the inserts (lower right). (Q,R) RealTime
PCR quantification of Bmp7 mRNA in WT, Dlx5K/K and Msx1K/K palatal tissue. Regression curves for GAPDH and Bmp7, and melting curves for Bmp7 are shown
(R), the calculated normalized ratio (mut/wt) is reported. Abbreviations as in previous figures.
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same sections were compared (insets in Fig. 5E,H). These
results are summarized in Fig. 7.
Noggin is expressed in chondrogenic condensations, in the
olfactory and VN epithelium, and in a restricted region of the
maxilla mesenchyme, but not in the palate proper (Fig. 5J).
Examination of serial sections of a WT embryo hybridized
with Dlx5 or Noggin indicates that expression of these two
genes in the maxillary region only partially overlaps (Fig. 5,
compare J and L, red arrows) and furthermore Noggin
expression did not significantly change in Dlx5K/K heads
(Fig. 5K). To control tissue preservation and specificity of
hybridization, Noggin signal on the ventricular zone of the
forebrain were compared (insets in Fig. 5J,K). For Dlx5,
control hybridization on the ganglionic eminence of the
forebrain is shown (inset in Fig. 5L). Finally, Chordin
expression in WT and Dlx5K/K palate was examined and
found not to change significantly (data not shown). As further
control for the relative position of the head territories and the
specificity of the observed differences, we examined
expression of the morphogens Wnt5a and Wnt5b. In E14.5
embryos, Wnt5a is expressed in the medial mesenchyme of
both the anterior and the posterior palate (Fig. 5M). In
Dlx5K/K palatal shelves Wnt5a expression is maintained in
the corresponding territory (Fig. 5N). Wnt5b is expressed in a
territory partly overlapping with Noggin and Dlx5 (Fig. 5P).
In Dlx5K/K heads Wnt5b expression in this domain is reduced
(Fig. 5Q) suggesting a generalized dysfunction of the Dlx5
expressing cells in this region.
2.6. The mandible and middle ear phenotypes
In the developing jaw Msx1nlacZ is expressed at E14.5 in a
large mesenchymal domain including the dental papilla, but
not in the dental epithelium (Fig. 6B,B’). In equivalent sections
Dlx5lacZ is expressed in osteogenic areas around the incisor
teeth buds (Fig. 6A,A’) and the Meckel’s cartilage (data not
shown), but not in the dental epithelium and papilla. Thus
expression of Dlx5 and Msx1 overlaps only in discrete regions
of osteogenic mesenchyme. The jaws of WT, Dlx5K/K,
Msx1K/K and DKO mice, as well as the combined genotypes
at P0, were compared (Fig. 6C–H). While both the Dlx5K/K
(Fig. 6D) and the Msx1K/K (Fig. 6F) jaws showed the expected
defects (Acampora et al., 1999; Depew et al., 1999; Satokata
and Maas, 1994), in the DKO jaw both the coronoid process
and the molar teeth are missing (Fig. 6H); these defects are
related, respectively, to the Dlx5 and the Msx1 null phenotypes.
Furthermore the DKO jaw is shorter and coarser compared to
the WT or to the Msx1K/K, although not as short as the
Dlx5K/K ones. This could be a reflection of the variability of
the Dlx5K/K phenotype (reported in Acampora et al., 1999;
Depew et al., 1999).
In the middle and inner ear region of E14.5 embryos
Dlx5lacZ is expressed in the malleus and incus (Fig. 6J), while
Msx1nlacZ is expressed in the malleus and the cochlea (Fig. 6K).
In DKO mice at P0 the malleus lacks the head and is deformed,
an Msx1-related phenotype and, conversely, an ectopic bone ispresent, a Dlx5 related phenotype (Fig. 6M–P). Thus, in the
middle ear region both the Msx1- and the Dlx5-related defects
can be recognized in the DKO.
Since, no novel defects or aggravations of known ones is
observed in the jaw and middle ear of DKO mice, Msx1 and
Dlx5 appear to have independent, non-overlapping functions in
these structures.
2.7. Other craniofacial phenotypes
In the DKO mice we observe a number of defects related to
those observed in the Dlx5K/K cranium (Table 1 summarized
in Table 1). No evident aggravation or rescue of these
phenotypes has been observed in the DKO, with the exception
of the vault bones which appear smaller, heavily perforated and
with irregular borders, the fontanels appear rather open on the
midline (see Supplementary material, Fig. S1). Msx1, but not
Dlx5, is expressed in the osteogenic calvaria mesenchyme of
the head in E14 embryos. Expression of Dlx5 in this tissue
appears at a later stage (E16) (Acampora et al., 1999; Holleville
et al., 2003, and data not shown). Interestingly, both the Msx1
and Dlx5 null mice show a delayed deposition of mineralized
tissue in their calvaria (Ryoo et al., 1997; Newberry et al.,
1998; Oreste-Cardoso et al., 2002; Acampora et al., 1999;
Satokata and Maas, 1994). This result might indicate a
cooperating function of these genes in osteoblast differen-
tiation. A delayed ossification of the fore- and hind-limbs is
also observed in the DKO mice (data not shown).3. Discussion
We report on the craniofacial phenotype of Msx1;Dlx5
DKO mice, compared with the defects in single Msx1 or Dlx5
mutants. Based on the specific defect and on their expression
pattern, we recognize these categories (see also Table 1):
(A) Non-overlapping defects affecting the same skeletal
element, indicating that Dlx5 and Msx1 have independent
functions (mandible and middle ear).
(B) Dlx5-related defects, with no aggravation (ectopic bone,
deformed pterigoids, basisphenoid and basioccipital,
disorganized foramina of the ala temporalis, hypoplasia
and asymmetry of the nasal and otic capsules).
(C) Msx1-related defects, with no aggravation (absence of
molar teeth and alveolar bone, deformation of the
squamosal).
(D) Phenotypic rescue (growth, elevation and ossification of
the palate). Since Msx1 and Dlx5 are not co-expressed,
this effect is non-cell-autonomous.
(E) Aggravation of defects affecting elements where genes are
co-expressed, indicating a synergistic function (deposition
of the calcified bone tissue in the calvaria and phalanges).
Since, the Dlx and Msx homeoproteins are known to form
heterodimers in vitro and the interaction leads to abrogation of
their DNA-binding and transcriptional activities (Zhang et al.,
1997), some of the phenotypes observed in Msx1 or in Dlx5
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protein partner, provided that these genes are co-expressed.
With the possible exception of the bone tissue, our data
indicate that in vivo functional interactions between Msx1 and
Dlx5 are unlikely to occur. The reason for this is two folds:
first, their expression territories in the embryonic head at E13–
E14 are to a large extent not overlapping; second, in the region
of co-expression these two genes carry out independent
morphogenetic functions, as demonstrated by the additive
feature of the jaw and middle ear phenotypes in DKO mice.
The expression of Msx2 is highly overlapping with that of
Msx1, while Msx3 is only expressed in the dorsal neural tube
(Alappat et al., 2003); therefore, functional interaction of Dlx5
with any of the Msx homeoproteins in vivo is improbable.
Alternatively, a repressor activity of Msx1 on Dlx5
expression was taken into consideration. Msx proteins are
mainly transcriptional repressors (Alappat et al., 2003), while
Dlx proteins are usually activators (Panganiban and Ruben-
stein, 2002). If this hypothesis was true, Dlx5 expression
should be augmented or expanded in Msx1K/K mice. However,
we did not observe changes in Dlx5 expression in the absence
of Msx1 and thus this possibility has been ruled out.3.1. Dlx and Msx genes in craniofacial and palate development
A variety of molecules have been implicated in signaling
during morphogenesis of facial primordia, including secreted
molecules (Shh, Bmp, Wnt, Fgf) and transcription factors (Dlx,
Otx, Msx, Gli and Tbx) (Wilkie and Morriss-Kay, 2001;
Francis-West et al., 2003; Richman and Lee, 2003). Towards
the understanding of how these molecules interact, one of the
most informative approaches is the observations of skeletal
phenotypes in mice with targeted mutations (Thyagarajan
et al., 2003). Failure of the palatal shelves to grow, elevate or
fuse on the midline is the basis of oro-facial cleft, or palatal
cleft, the most frequent craniofacial malformation in babies
(Ferguson, 1998). Cleft palate results from the disturbance
of tightly controlled events that are regulated by a number
of molecules (Houdayer and Bahuau, 1998; Marazita
and Mooney, 2004; Johnston and Bronsky, 1995; Prescott et
al., 2001; Murray and Schutte, 2004; Kaartinen et al., 1995;
Matzuk et al., 1995; Proetzel et al., 1995; Peters et al., 1998;
Miettinen et al., 1999; Szeto et al., 1999; Zhao et al., 1999).
Mutation or disruption of the MSX1/Msx1 genes causes in both
human and mice oro-facial cleft and tooth agenesis (Satokata
and Maas, 1994; Vastardis et al., 1996; Houzelstein et al.,
1997; van den Boogaard et al., 2000). In the mouse palatal cleft
is associated with a downregulation of Bmp4 in the anteriorFig. 5. Expression of Follistatin, Noggin, Wnt5a and Wnt5b in Dlx5K/K, Msx1K/K
posterior (E,F,G,H) palate of WT (A,E), Dlx5K/K (B,F), Msx1K/K (C,G) and DKO (
Control hybridizations from the same experiment (molar tooth buds) are shown for ea
Dlx5K/K (K) embryonic heads at E13.5, compared to expression of Dlx5 in adjace
maxillary mesenchyme that overlaps with Dlx5. Control hybridizations from the sam
in the lower-right insets. Expression of Wnt5a (M,N) and Wnt5b (P,Q) in WT (M,P) a
in the palatal mesenchyme (black arrows in M) and is unchanged in the Dlx5K/K spe
to the palatal shelves (sketched in P); In the Dlx5K/K expression is reduced (red arro
as in previous figures.palate (discussed below). Disruption of Dlx genes also causes
palatal cleft (Acampora et al., 1999; Depew et al., 1999; Qiu
et al., 1997), although they are not expressed in the palatal
mesenchyme. Disruption of Dlx5 leads to a less severe cleft, as
compared to Msx1: the shelves are usually present and
elevated, however, fail to grow properly and to fuse on the
midline. Three mechanisms can be proposed: either Dlx genes
instruct cells precursor of the palatal anlage early in
development (i.e. neural crest or arch ectomesenchyme,
where they are expressed), or they control expression of
secreted diffusable molecules, or the cleft is the consequence of
a generalized deformation of the cranium. With respect to this
last possibility, recent data indicate that apoptosis of MEE
cells, essential for fusion of the shelves, is sensitive to the
distance between the shelves (Gurley et al., 2004). It is
conceivable that palate closure requires a threshold of physical
inter-shelf distance not to be exceeded, a distance that can vary
as a consequence of dysmorphologies of the cranium. This
could partly explain the Dlx5K/K palatal cleft, in fact its
severity correlates with the general severity of other
craniofacial defects (unpublished). However, the palatal
shelves of the DKO appear more normal than those of either
of the single mutants, in spite of the generalized distortion, and
therefore, the palatal rescue is not directly related to other
craniofacial abnormalities.
The craniofacial phenotypes of Msx and Dlx mutant mice
could be interpreted according to two (non-mutually exclu-
sive) models: one in which Msx and Dlx confer spatial identity
to the ectomesenchymal cells in a cell-autonomous way, the
second in which they mediate non-cell-autonomous instructive
signals converging on the regulation of specific signaling
centers. In this study, we provide evidence for a non-cell-
autonomous cooperation between Dlx5 and Msx1 during
palate growth, elevation and ossification: these genes are
expressed in adjacent domains, with Msx1 but not Dlx5 present
in the palate proper. During organ development, interactions
between neighboring tissue layers are crucial for growth,
morphogenesis and differentiation (Richman and Tickle, 1992;
Thesleff et al., 1995). Palatogenesis as well critically requires
interactions between the crest-derived mesenchyme and the
overlying epithelium (Slavkin, 1984; Ferguson and Honig,
1984). Recently, a restricted region of the anterior palate is
coming to attention as a signaling center. This region
expresses a several morphogenetic molecules including
Shh, Bmp, Wnt, Msx1, but not Dlx5 or Dlx6 (unpublished
data). Zhang and coworkers (2002) have shown that cell
proliferation is reduced in the anterior palatal mesenchyme
of Msx1K/K mice, (see also mice Hu et al., 2001),and DKO embryos. (A–H) Follistatin expression in the anterior (A,B,C,D) and
D,H) embryos at E13.5. Red arrows indicate the signal on the palatal epithelium.
ch genotype in the lower-right insets. (J–L) Expression of Noggin in WT (J) and
nt sections of the WT specimen (L). Red arrows indicate Noggin signal in the
e experiment (ganglionic eminence of the forebrain) are shown for both probes
nd Dlx5K/K (N,Q) embryonic heads at E14.5. Expression of Wnt5a is observed
cimen (N). Expression of Wnt5b in observed in a mesenchymal domain, lateral
w in Q). The section and viewing planes are the same as in Fig. 4. Abbreviations
Fig. 6. Craniofacial defects in Msx1-Dlx5 DKO mice. (Top) the mandible. (A,B’) X-gal staining of frontal sections of Dlx5lacZ (A,A’) and Msx1nlacZ (B,B’) heterozygous
embryos at E14.5. The section planes are clarified in the drawing on the right. Expression of Dlx5 is found in the osteogenic mesenchyme (OM) around the incisor teeth (A’),
but not in the dental papilla (DP) (double arrow in A’). Expression of Msx1 is found in the anterior mesenchyme (B), in the OM of the jaw and in the dental papilla (DP) of the
incisor teeth (double arrow in B’). Neither Dlx5 nor Msx1 are expressed in the dental epithelium (DE). The clarify the expression territories in A’ and B’, the position of OM,
DE and DP in the developing incisor tooth is sketchedon the right. (C–H) Dissected mandible at P0. The normal jaw is shown in C, the DKO is shown in H. Black arrowheads,
coronoid process; red arrowheads, molar tooth; asterisks indicate missing structures. (Bottom) the middle ear. (J,K) Expression of Dlx5lacZ (J) and Msx1nlacZ (K) in E14.5
heterozygous embryos. (L–P) Skeletal structures of the middle ear at P0. Black arrows indicate the head of the malleus; yellow asterisks (M,P) indicate the ectopic bone. Note
that in L–N the styloid process has been dissected out, and that due to distortions of the cranium, the samples M and P are slightly rotated to allow visualization of the Malleus.
Abbreviations: Co, cochlea; DE, dental epithelium; DP, dental papilla; In, incus; Ma, malleus; MC, Meckel’s cartilage; Md, mandible; OM, osteogenic mesenchyme; Sty,
styloid process; T, tongue; TR, tympanic ring. Scale bar in CZ1 mm. Values reported in C–H (on the right) indicate the length of the jaw, in mm.
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Importantly, exogenous expression of Bmp4 in the same
region could restore normal cell proliferation, Shh and Bmp2
expression, and palatal elevation. These results clearlyindicate that Msx1 controls a genetic hierarchy that entails
transcription activation of Bmp4 in a limited co-expression
territory, and this in turn controls expression of Shh and
Bmp2.
Table 1
Summary of the skeletal defect in Dlx5-Msx1 DKO mice
Structure Dlx5–Msx1 DKO (1) Dlx5 mutant (1) Expression of Dlx5 (2) Msx1 mutant (1) Expression of Msx1 (2)
Mandible Missing molars and
coronoid process
Missing coronoid pro-
cess
Yes Missing molars Yes
Middle ear Malleus deformed
presence of strut
Presence of strut Yes Malleus deformed Yes
Calvaria Severe delay (3) Mild delay (3) Late Mild delay (3) Early
Otic capsule Deformation of the
vestibular region
Deformation of the
vestibular region
Yes – –
Nasal cavity Deformed, asymmetric Deformed, asymmetric Yes – –
Lamina obturans Foramina disorganized
or missing
Foramina disorganized
or missing
Yes – –
Palatal shelves Formed, elevated, partl.
ossified but reduced
and unfused
Formed, elevated, partl.
ossified but reduced
and unfused
No Severely reduced, not
elevated, unfused
Yes
Limb morphology Normal Normal Yes Normal Yes
Limb ossification Delayed (3) Slightly delayed (3) Slightly delayed (3)
(1) Skeletal defects (cartilages and bones) observed at P0. (2) The expression columns combine data from this paper (E13.5 and E14.5) and from published literature.
(3) Retardation of mineralized bone deposition
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rescues the Msx1-dependent defect via increased Bmp7 and
reduced Follistatin expression. This observation links Msx1
and Dlx5 in the regulation of a common signaling system
critical for palate morphogenesis, as a result of cell non-
autonomous interactions between adjacent cells and tissues; in
fact Bmp4 is expressed in the anterior signaling center, while
Bmp7 and Follistatin are expressed in a wider domain, along
the antero-posterior length of the epithelium. In Dlx5K/K and
DKO embryos Bmp7 is increased throughout the palate, while
Follistatin is decreased posteriorly. Furthermore, Dlx5 and
Dlx6 are not expressed in the anterior palate, where the Msx1-
Bmp4 regulation takes place. Together, these observations
suggest that the restoration of palate growth and elevation
might result from a recruitment of the central-posterior palate
tissue via enhancement of Bmp functions posteriorly.Fig. 7. Schematic drawing of the relative expression territories of Bmp7 (red)
and Follistatin (green) in the anterior and posterior palate of WT (upper left),
Msx1K/K (upper right), Dlx5K/K (lower left) and DKO (lower right) embryos
at E13.5. The medial-lateral (Med, Lat) and the Nasal-Oral (N, O) axes and
directions are shown. In the posterior palate expression in the molar tooth (Mo)
is also indicated. For a detailed description, see the Section 2.3.2. Bmp signaling and palate morphogenesis
The expression pattern of Bmp2 and K4 is highly
reminiscent of that found in other embryonic territories
where fusion occurs, such as the frontonasal processes (Gong
and Guo, 2003). Midline fusion of the palatal shelves, thus, is
one more example of this important function of Bmp
molecules. Bmp4 is also likely to carry out a morphogenetic
function in the palatal primordia prior to their fusion, since the
palatal shelves of Msx1K/K mice never come in proximity
(Zhang et al., 2002). Interestingly, in the corresponding region
of the palate the Bmp-antagonist Follistatin (Balemans and
VanHul, 2002) is only expressed in a restricted dorsal (nasal)
domain but not in the signaling center (our data) and might
serve the function to restrict the Bmp2 and -4 activity to the tip
of the shelves.
The rescue of palatal formation in the DKO can be
explained by the increased Bmp7 expression compensating
for the reduction of Bmp4 (Fig. 7). Indeed, disruption of
Dlx5 leads to an up-regulation of Bmp7 expression in the
palate, also observed in the DKO palate. Bmp7 may servethe dual function of stimulating growth of the palatal
mesenchymal cells, a function known for Bmp4 (Zhang
et al., 2002), and that of inducing ossification at later stages
(Franceschi et al., 2000). The possibility that Bmp7 may
functionally substitute for other Bmps is supported by the
analysis of skeletal phenotypes in compound Bmp mutant
mice, showing redundancy in vivo (Zhao, 2002; Goumans
and Mummery, 2000; Dudley et al., 1995; Luo et al., 1995;
Jena et al., 1997; Solloway and Robertson, 1999); in
particular Bmp4;Bmp7, but not Bmp2;Bmp7 or Bmp5;Bmp7,
double heterozygotes show skeletal abnormalities (Katagiri
et al., 1998), an indication that Bmp4 and Bmp7 might
synergistically regulate a common mechanism. At the
receptor level, several type I and type II subunits bind
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Goumans and Mummery, 2000; Zhao, 2002). Biochemically
it is unclear which ligand binds to which receptor complex,
and receptor-ligand binding appears to be rather promiscu-
ous. At the transduction level, Bmp4 binds to the Alk3/Alk6
receptors (BMP-R type IA and IB, respectively), while Bmp7
preferentially binds to Alk2 (Aoki et al., 2001); however all
these receptors induce activation of Smad8 (Kawai et al.,
2000). Thus, in selected biological systems Bmp molecules
might be able to compensate each other’s activity.
The rescue of palate morphogenesis in the DKO could also
be favored by the reduced Follistatin expression observed in
the Dlx5K/K palate (Fig. 7). Follistatin is a diffusible molecule,
whose altered concentration may likely affect adjacent
territories, including more anterior palatal domains. The effect
should be that of a reduced Bmp antagonist activity in the
medial and posterior palatal mesenchyme, where Bmp7 is over-
expressed. Functionally, these two effects go in the same
direction, since they are expected to potentiate Bmp signaling.
The changes in Bmp7 and Follistatin expression in Dlx5K/K
embryos occur at a location in which Dlx5 is not expressed,
indicating the cell non-autonomous nature of the palatal
rescuing. In the Msx1K/K palatal shelves Follistatin expression
is reduced anteriorly but is maintained posteriorly.
In summary, the effect of the Dlx5 mutation on the Bmp
system during palate formation consists in a non-cell-
autonomous regulation on the expression of Bmp7 and
Follistatin with the result of potentiating the Bmp signal.
This strengthens the notion that the tight regulation of
expression and activity of this class of molecules is essential
in the coordination of cellular events leading to growth,
morphogenesis and fusion of embryonic structures. More
generally, our findings are an illustration of the importance of
non-cell-autonomous signaling between adjacent territories, a
less well explored level of regulation during embryonic
morphogenesis.4. Experimental procedures
4.1. Targeted disruption of Dlx5 and Msx1
Mice with targeted disruption of Dlx5 have been reported (Acampora et al.,
1999). The targeted allele has the 1st and 2nd exons replaced by the lacZ
reporter. The modified null allele, denominated Dlx5lacZ, allows for detection of
the Dlx5-expressing cells by staining for b-galactosidase (b-gal) expression. In
all the territories examined b-gal expression recapitulates known Dlx5
expression. Genotypes of the Dlx5 mice were determined as described
(Acampora et al., 1999). Mice with a targeted inactivation of Msx1 have been
reported (Houzelstein et al., 1997). In the targeted allele the nlacZ reporter gene
was introduced in phase into the Msx1coding sequence. The modified allele
denominated Msx1nlacZ, allows for the detection of Msx1-expressing cells by
staining for b-gal. Genotypes of the Msx1 mice were determined by PCR using
the following primers:
WT: primer A: 5 0 CGCGCTGGAAAGGGCC
primer B: 5 0 CTATTGCCGAGCGCGCG
mutant: primer C: 5 0 TTCAGGCTGCGCAACTGTT
primer B (as above)4.2. Phenotype analysis
Skeletal staining of newborn animals was carried out as previously
described (Alizarin and Alcian Blue, Acampora et al., 1999). Whole-mount
detection of b-gal was done on E12.5–E14.5 embryos as described (Merlo
et al., 2002). For histological detection of b-gal, E13.5 and E14.5 embryos was
fixed with 4% PAF 20’ RT, followed by washes in PBS, sectioning by
vibratome (80 mm) and staining as described (Perera et al., 2004).
In situ hybridization was carried out with DIG-labeled antisense probes for
the following genes: Dlx5, a 750 bp fragment spanning the coding sequence;
Dlx6, a 350 bp fragment spanning exons 3 and 4 (Perera et al., 2004); Msx1, a
550 bp 3 0 spanning the homeodomain; Msx2, containing exon 1; Noggin,
obtained from R. Harland (Berkeley, Univ., CA); Nhordin, from Dr J. Belo
(Inst Gulbenkian de Cienca, Oeiras, Portugal) and Bmp4, from Dr E. Bober
(Martin-Luther Univ., Halle Germany). Probes for murine Bmp7 and Follistatin
were obtained by RT-PCR from mouse embryo cDNA and corresponded to,
respectively, a 511 bp fragment of the 3 0UTR and a 534 bp fragment of coding
plus 3 0UTR sequences. With each probe, at least two normal and three mutant
specimens were examined. For the palate, frontal 100 mm vibratome sections or
12 mm cryostatic sections from E13.5–E14.5 embryos were obtained serially.
Hybridization on vibratome floating slices or on cryostatic sections was
performed as described (Perera et al., 2004; Zhadanov et al., 1995), signal was
revealed with BM-Purple (Roche).
4.3. RNA quantification by real-time PCR
E14.5 palatal shelves (6 WT and six mutants, two independent
experiments) were accurately dissected, pooled in TriPure Reagent (Roche)
and extracted as indicated by the manufacturer. As Bmp7 is not expressed in
nearby tissues, the only source is the medial palatal mesenchyme. RNA
quality, primer efficiency and correct size were tested by RT-PCR and
agarose gel electrophoresis. RealTime was performed with LightCycler
(Roche) using FastStart DNA MasterPLUS SYBR-Green I (Roche). Five
microlitres of cDNA were used in each reactions, standard curve were
performed using WT cDNA with four calibration points: 1:10; 1:40; 1:160;
1:640. All samples were in duplicates. Specificity and absence of primer
dimers was controlled by denaturation curves. GAPDH was used for
normalization, calculated using LightCycler Software 3.5.3. Primer
sequences are:
GAPDH S 5 0 TGTCAGCAATGCATCCTGCA 3 0
GAPDH AS 5 0 TGTATGCAGGGATGATGTTC 3 0
Bmp7 F 5 0 GCGATTTGACAACGAGACCT 30
Bmp7 R 5 0 AGGGTCTCCACAGAGAGCTG 3 0Acknowledgements
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